Emily Delzer
Internal Medicine · Centennial, CONPI 1285219121
Payments from drug & device makers
Across 85 payments — averaging $21.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$315
- Novo Nordisk$229
- AstraZeneca$208
- Exact Sciences$165
- GSK$102
- Edwards Lifesciences$92
- plus $714 from 19 others
What the payments were for
- Food & beverage$1,825100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 16 | $315 |
| Novo Nordisk | 12 | $229 |
| AstraZeneca | 9 | $208 |
| Exact Sciences | 9 | $165 |
| GSK | 4 | $102 |
| Edwards Lifesciences | 3 | $92 |
| Philips North America LLC | 3 | $87 |
| Seqirus USA Inc | 3 | $71 |
| Lilly USA, LLC | 4 | $68 |
| Merck | 3 | $61 |
| Idorsia Pharmaceuticals US Inc | 3 | $46 |
| Abiomed | 1 | $43 |
| Lucid Diagnostics Inc. | 2 | $40 |
| Dexcom, Inc. | 2 | $38 |
| AbbVie | 1 | $32 |
| Teva Pharmaceuticals USA, Inc. | 1 | $31 |
| Abbott | 1 | $30 |
| Boehringer Ingelheim | 1 | $29 |
| Biogen | 1 | $23 |
| Johnson & Johnson | 1 | $21 |
| Bayer | 1 | $20 |
| Gilead | 1 | $20 |
| Aimmune Therapeutics, Inc. | 1 | $20 |
| Inogen, Inc. | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
How this compares
$1,825 in reported general payments places this provider in the 85th percentile of 1,430 internal medicine providers in Colorado.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 39 | $64,933 |
| OzempicSemaglutide | 35 | $33,773 |
| TrulicityDulaglutide | 19 | $24,894 |
| MyrbetriqMirabegron | 21 | $17,555 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 15 | $1,879 |
| Levothyroxine Sodium | 115 | $1,445 |
| Estradiol | 23 | $1,412 |
| Omeprazole | 69 | $1,386 |
| Gabapentin | 69 | $1,251 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 12 | $1,214 |
| Duloxetine Hcl | 24 | $1,038 |
| Ropinirole Hcl | 24 | $904 |
| Atorvastatin Calcium | 125 | $899 |
| Tamsulosin Hcl | 65 | $786 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 31 | $586 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $315 | $64,93339 claims |
| Novo NordiskOzempic | $229 | $33,77335 claims |
| Lilly USA, LLCTrulicity | $68 | $24,89419 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,430 internal medicine providers in Colorado.
Other internal medicine in Centennial
- Joel ShebowichCentennial$32K
- Jill SchofieldCentennial$10K
- Stanton ElziWheat Ridge$9.2M
- Jason HenryDenver$7.3M
- Kenneth CohenLakewood$4.5M
- Luke WebbColorado Springs$2.1M
- Alexis LealAurora$2M
- Mauricio WaintrubAurora$1.3M
- Steven BrodieColorado Springs$883K
- Monica GrafalsAvon$673K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.